Elevance Health, Inc.

  • Market Cap: Large Cap
  • Industry: Healthcare Services
  • ISIN: US0367521038
USD
333.49
2.74 (0.83%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Elevance Health, Inc. stock-summary
stock-summary
Elevance Health, Inc.
Healthcare Services
Anthem, Inc. is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products. It also provides an array of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs and other administrative services. It provides an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits and radiology benefit management.
Company Coordinates stock-summary
Company Details
220 Virginia Avenue , INDIANAPOLIS IN : 46204
stock-summary
Tel: 1 317 4886000
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 210 Schemes (36.74%)

Foreign Institutions

Held by 567 Foreign Institutions (22.43%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Ms. Elizabeth Tallett
Independent Chairman of the Board
Ms. Gail Boudreaux
President, Chief Executive Officer, Director
Mr. R. Kerry Clark
Independent Director
Mr. Robert Dixon
Independent Director
Mr. Lewis Hay
Independent Director
Ms. Julie Hill
Independent Director
Dr. Bahija Jallal
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
1,744 Million
stock-summary
Industry

Healthcare Services

stock-summary
Market cap

USD 69,391 Million (Large Cap)

stock-summary
P/E

15.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

173.23%

stock-summary
Debt Equity

-0.11

stock-summary
Return on Equity

12.23%

stock-summary
Price to Book

1.59